Co-Authors
This is a "connection" page, showing publications co-authored by Salequl Islam and Rimple Kaur.
Connection Strength
0.409
-
Favipiravir Use in COVID-19: Analysis of Suspected Adverse Drug Events Reported in the WHO Database. Infect Drug Resist. 2020; 13:4427-4438.
Score: 0.230
-
Cardiovascular Adverse Events Reported from COVID-19 Vaccines: A Study Based on WHO Database. Int J Gen Med. 2021; 14:3909-3927.
Score: 0.120
-
Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database. Expert Opin Drug Saf. 2021 Sep; 20(9):1125-1136.
Score: 0.060